دورية أكاديمية
Disparities in Neuro-Oncology.
العنوان: | Disparities in Neuro-Oncology. |
---|---|
المؤلفون: | Michaelson NM; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Watsula A; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Bakare-Okpala A; Department of Neurology, Weill Cornell Medicine, New York, NY, USA., Mohamadpour M; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, C719, USA., Chukwueke UN; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Budhu JA; Department of Neurology, Weill Cornell Medicine, New York, NY, USA. budhuj@mskcc.org.; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, C719, USA. budhuj@mskcc.org. |
المصدر: | Current neurology and neuroscience reports [Curr Neurol Neurosci Rep] 2023 Dec; Vol. 23 (12), pp. 815-825. Date of Electronic Publication: 2023 Oct 27. |
نوع المنشور: | Journal Article; Review |
اللغة: | English |
بيانات الدورية: | Publisher: Current Science Inc Country of Publication: United States NLM ID: 100931790 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6293 (Electronic) Linking ISSN: 15284042 NLM ISO Abbreviation: Curr Neurol Neurosci Rep Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Philadelphia, PA : Current Science Inc., c2001- |
مواضيع طبية MeSH: | Central Nervous System Neoplasms*/diagnosis , Central Nervous System Neoplasms*/therapy, Humans ; Medical Oncology ; Forecasting |
مستخلص: | Purposeof Review: Health disparities are preventable differences in the diagnosis, treatment, and outcomes of many diseases, including central nervous system (CNS) tumors. This review will summarize and compile the existing literature on health disparities in neuro-oncology and provide directions for future research and interventions. Recent Findings: Patients from historically marginalized groups are more likely to receive inadequate treatment, develop complications, and experience a shorter life expectancy. Financial toxicity can be particularly severe for patients with CNS tumors due to the high costs of treatment. Additionally, CNS clinical trials and research lack diverse representation. (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.) |
فهرسة مساهمة: | Keywords: Brain tumors; Central nervous system tumors; Health disparities; Health equity; Neuro-oncology; Social determinants of health |
تواريخ الأحداث: | Date Created: 20231027 Date Completed: 20231216 Latest Revision: 20240531 |
رمز التحديث: | 20240531 |
DOI: | 10.1007/s11910-023-01314-x |
PMID: | 37889427 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1534-6293 |
---|---|
DOI: | 10.1007/s11910-023-01314-x |